PhillipCapital
VC Fund
Singapore, Singapore
PhillipCapital is a VC fund in Singapore focused on Financial Services and FinTech. Since 1975, PhillipCapital has grown as an integrated Asian financial house with a global presence that offers a full range of quality and innovative services to retail, corporate and institutional customers. Our comprehensive suite of financial products and services includes fund management, managed accounts, unit trusts, insurance planning, regular savings, contracts for difference, exchange traded funds, investment research, equity financing, property; and broking in bonds, securities, futures, foreign exchange, precious metals and commodities. Institutions can also benefit from our corporate finance and advisory services as well as information technology solutions. With more than 3,500 employees and over 800,000 clients worldwide, our assets under management totals to more than USD 22 Billion with shareholders' funds in excess of USD 1 Billion. PhillipCapital (with headquarters in Singapore) operates in the financial hubs of 16 countries, with offices in Singapore, Malaysia, Cambodia, Indonesia, Thailand, Hong Kong, China, Japan, India, Sri Lanka, UAE, UK, France, Turkey, Australia and USA.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 67%
Last updated:
For AI agents: llms.txt
Industries PhillipCapital invests in
Stages PhillipCapital invests in
Countries PhillipCapital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $2.3M–$4M
- Series A
- $2.4M–$5M
- Series B
- $4M–$20M
Investment Focus
Industry
- Financial Services 5 (42%)
- FinTech 3 (25%)
- Finance 3 (25%)
- Health Care 2 (17%)
- Biotechnology 2 (17%)
Stage
- Seed 2 (17%)
- Series A 2 (17%)
- Series B 2 (17%)
- Pre-Seed 1 (8%)
- Series C 1 (8%)
Country
- United States 4 (33%)
- Singapore 2 (17%)
- India 1 (8%)
- Malaysia 1 (8%)
- United Kingdom 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
John J. Kaminsky
Chief Compliance Officer
|
Chief Compliance Officer | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Walker Crips Asset Managers provides financial services in the United Kingdom. The company operates through two segments, Investment Management and Wealth Management. It offers bespoke discretionary and advisory management services, as well as discretionary fund management; structured investment arrangement and administration services; stockbrokingservices, including advisory dealing and execution-only services; and alternative investment products and services. The company also provides financial planning, pension administration, and investment management solutions. | $6.6M / Post-IPO Debt / Jul 31, 2025 | ||
| Navi is building consumer-centric and technology-driven businesses in the BFSI (Banking, Financial Services & Insurance) space. | $19.6M / Debt Financing / Jul 28, 2025 | ||
| Fintech Investments Platform that specializes in the alternative lending space in South-east Asia & Oceania. The company addresses the funding gap faced by small and medium-sized enterprises (SMEs) and individuals in Southeast Asia, which are often underserved by traditional financial institutions. Helicap's platform offers investorsaccess to curated investment opportunities that focus on generating attractive returns while managing risk effectively. | $5M / Series A / Jun 22, 2022 | ||
| Capital C Corporation is a Singapore-based financial services provider. Capital C Corporation capitalises on fintech and the best emerging technologies in the market to provide financial services to the under-served in Singapore. | $53.8M / Pre-Seed / Jun 08, 2022 | ||
| WORQ is Malaysia's biggest co-working space. WORQ creates a large and most productive co-working community, taking care of all workplace needs and facilitating deeper connection. | $2.3M / Seed / Sep 23, 2020 | ||
| WORQ is Malaysia's biggest co-working space. WORQ creates a large and most productive co-working community, taking care of all workplace needs and facilitating deeper connection. | $2.4M / Series A / Sep 23, 2020 | ||
| The Small Exchange conducts more participants to financial markets with simpler and smaller futures products. The company creates a future exchange to execute the trading of proprietary products for all types of market participants, with a focus on the public retail customer. It enables traders access to exclusive products that will develop newtrading opportunities for investors of all sizes.The Small Exchange was founded in 2017 and is based in Chicago, Illinois. | $4M / Seed / Jun 03, 2020 | ||
| WORQ is Malaysia's biggest co-working space. WORQ creates a large and most productive co-working community, taking care of all workplace needs and facilitating deeper connection. | $2.5M / Equity Crowdfunding / Jul 09, 2018 | ||
| Amaranth Medical‘s mission is to transform the field of interventional cardiology and beyond by providing fully bioresorbable, versatile scaffolds with unprecedented mechanical properties. We strive to become the new global standard of care for stent interventions. Amaranth is dedicated to advancing the practice of medicine and improving thelong-term health of patients worldwide.The Amaranth flower, derived from the Greek word “never fading,” stands as the emblem of our company. Like the Amaranth, a symbol of immortality and adaptability, our scaffold solutions are enduring — designed to deliver lasting clinical benefits, long after the polymeric device resorbs and disappears. | $20M / Series B / Oct 08, 2013 | ||
| Prolacta Bioscience, Inc. (www.prolacta.com) is a life science company founded by serial entrepreneur, Elena Medo who has dedicated her career to improving quality of life for sick infants by Advancing the Science of Human MilkTM. Prolacta creates specialty formulations made exclusively from human milk for the nutritional needs of critically ill,premature infants in neonatal intensive care units. It is the first and only company to provide a human milk fortifier made from 100% human milk, Prolact+ H2MF. They operate a pharmaceutical grade processing plant and have designed and patented processes that enable them to make their one-of-a-kind life saving products. Prolacta is committed to making a meaningful difference in the lives of the most vulnerable infants through world-class research and innovative products. | $12M / Series C / May 23, 2007 | ||
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does PhillipCapital invest in?
PhillipCapital invests primarily in Financial Services, FinTech and Finance startups, most often at Seed and Series A stage. Most of the 12 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does PhillipCapital invest in?
PhillipCapital typically joins rounds of $2.3M–$4M at Seed, $2.4M–$5M at Series A and $4M–$20M at Series B. These are whole funding-round sizes, not PhillipCapital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds PhillipCapital took part in.
How do I contact PhillipCapital?
Public channels for PhillipCapital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at PhillipCapital?
The team at PhillipCapital includes John J. Kaminsky (Chief Compliance Officer). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Nov 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
